Steroid-toxicity insights

Myasthenia gravis is a rare immune-mediated disorder (affecting less than 100,000 patients in the US) in which the immune system mistakenly targets nerves or muscles. Historically, myasthenia gravis ...

“We're using the same tools that demonstrate the benefit of our drugs to show that the long-term cost of steroids has been vastly underestimated.” Glenn Philips, PhD is the Vice President of Health ...

A pioneering analysis of electronic health record (EHR) data from the Optum® EHR database has shown that it is finally possible to quantify the risk-to-benefit ratio of prescribing glucocorticoids, ...

During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...

Although ongoing research continues to advance our understanding of IgG4-related disease (IgG4-RD), the epidemiology and downstream consequences of this relatively rare and complex autoimmune ...